WallStreetZenWallStreetZen

NASDAQ: ANAB
Anaptysbio Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANAB

Based on 8 analysts offering 12 month price targets for Anaptysbio Inc.
Min Forecast
$20.00+0.65%
Avg Forecast
$44.63+124.58%
Max Forecast
$80.00+302.62%

Should I buy or sell ANAB stock?

Based on 8 analysts offering ratings for Anaptysbio Inc.
Buy
Strong Buy
4 analysts 50%
Buy
1 analysts 12.5%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ANAB stock forecasts and price targets.

ANAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-04-01
lockedlocked$00.00+00.00%2024-02-26
lockedlocked$00.00+00.00%2024-02-21
Piper Sandler
Top 5%
96
Strong BuyInitiates Coverage On$80.00+302.62%2024-02-16
Wedbush
Top 4%
97
HoldReiterates$20.00+0.65%2023-11-29
UBS
Top 20%
81
HoldMaintains$21.00+5.69%2023-11-02

1 of 1

Forecast return on equity

Is ANAB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is ANAB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ANAB revenue forecast

What is ANAB's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$21.9M+27.8%
Avg 2 year Forecast
$31.3M+82.49%
Avg 3 year Forecast
$41.6M+142.44%
ANAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ANAB revenue growth forecast

How is ANAB forecast to perform vs Biotechnology companies and vs the US market?
Company
34.06%
Industry
38.03%
Market
10.06%
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANAB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANAB$19.87$44.63+124.58%Buy
EXAI$4.24$9.00+112.26%Hold
MESO$5.21N/AN/A
ATXS$9.75$21.75+123.08%Strong Buy
KRRO$66.74$126.25+89.17%Strong Buy

Anaptysbio Stock Forecast FAQ

Is Anaptysbio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: ANAB) stock is to Buy ANAB stock.

Out of 8 analysts, 4 (50%) are recommending ANAB as a Strong Buy, 1 (12.5%) are recommending ANAB as a Buy, 3 (37.5%) are recommending ANAB as a Hold, 0 (0%) are recommending ANAB as a Sell, and 0 (0%) are recommending ANAB as a Strong Sell.

If you're new to stock investing, here's how to buy Anaptysbio stock.

What is ANAB's revenue growth forecast for 2024-2026?

(NASDAQ: ANAB) Anaptysbio's forecast annual revenue growth rate of 34.06% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Anaptysbio's revenue in 2024 is $17,157,000.On average, 4 Wall Street analysts forecast ANAB's revenue for 2024 to be $586,834,077, with the lowest ANAB revenue forecast at $321,156,972, and the highest ANAB revenue forecast at $990,233,997. On average, 4 Wall Street analysts forecast ANAB's revenue for 2025 to be $837,952,066, with the lowest ANAB revenue forecast at $321,156,972, and the highest ANAB revenue forecast at $1,445,206,374.

In 2026, ANAB is forecast to generate $1,113,210,354 in revenue, with the lowest revenue forecast at $888,266,658 and the highest revenue forecast at $1,338,154,050.

What is ANAB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ANAB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ANAB's Price Target?

According to 8 Wall Street analysts that have issued a 1 year ANAB price target, the average ANAB price target is $44.63, with the highest ANAB stock price forecast at $80.00 and the lowest ANAB stock price forecast at $20.00.

On average, Wall Street analysts predict that Anaptysbio's share price could reach $44.63 by Apr 16, 2025. The average Anaptysbio stock price prediction forecasts a potential upside of 124.58% from the current ANAB share price of $19.87.

What is ANAB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ANAB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.